Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Holders of 5% or more of OYST
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oyster Point Pharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Oyster Point Pharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Oyster Point Pharma, Inc., newest first.
No Schedule 13D or 13G filings on Oyster Point Pharma, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Oyster Point Pharma, Inc. shares.
No Form 144 notices for Oyster Point Pharma, Inc. are on file.